Research Progress on the Mechanism Between Polycystic Ovary Syndrome and Abnormal Endometrium
- PMID: 34975540
- PMCID: PMC8718643
- DOI: 10.3389/fphys.2021.788772
Research Progress on the Mechanism Between Polycystic Ovary Syndrome and Abnormal Endometrium
Abstract
As a highly dynamic tissue, the endometrium is periodically shed in response to the secretion of estrogen and progesterone. After menarche, the endometrium of healthy women proliferates and differentiates under the action of steroid hormones (e.g., 17β-estradiol and progesterone) that are secreted by the ovaries to provide appropriate conditions for embryo implantation. Polycystic ovary syndrome (PCOS), a prevalent endocrine and metabolic disorder in reproductive-aged women, is usually associated with multiple cysts within the ovaries and excess levels of androgen and is characterized by hirsutism, acne, menstrual irregularity, infertility, and increased risk of insulin resistance. Multiple factors, such as anovulation, endocrine-metabolic abnormalities, and inflammation, can disrupt the endometrium in PCOS patients and can lead to endometrial hyperplasia, pregnancy complications, or even cancer. Despite many recent studies, the relationship between PCOS and abnormal endometrial function is still not fully understood. In this review, we investigate the correlation of PCOS patient endometrium with anovulation, hyperandrogenemia, insulin resistance, progesterone resistance, and inflammatory cytokines, aiming to provide a theoretical basis for the treatment of disorders caused by endometrial dysfunction in PCOS patients.
Keywords: anovulation; endometrium; hyperandrogenemia; inflammatory cytokines; insulin resistance; polycystic ovary syndrome; progesterone resistance.
Copyright © 2021 Xue, Li, Feng, Han, Zhao, Zhang, Han, Wu and Zhang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC. Endocr Pract. 2015. PMID: 26509855
-
Uterine Function: From Normal to Polycystic Ovarian Syndrome Alterations.Curr Med Chem. 2018;25(15):1792-1804. doi: 10.2174/0929867325666171205144119. Curr Med Chem. 2018. PMID: 29210631 Review.
-
Endometrium in PCOS: Implantation and predisposition to endocrine CA.Best Pract Res Clin Endocrinol Metab. 2006 Jun;20(2):235-44. doi: 10.1016/j.beem.2006.03.005. Best Pract Res Clin Endocrinol Metab. 2006. PMID: 16772154 Review.
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2. Endocr Pract. 2015. PMID: 26642102 Review.
-
Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.Hum Reprod. 2014 Jul;29(7):1526-35. doi: 10.1093/humrep/deu114. Epub 2014 May 19. Hum Reprod. 2014. PMID: 24842895
Cited by
-
Progress of the application clinical prediction model in polycystic ovary syndrome.J Ovarian Res. 2023 Nov 25;16(1):230. doi: 10.1186/s13048-023-01310-2. J Ovarian Res. 2023. PMID: 38007488 Free PMC article. Review.
-
Supraphysiological Dose of Testosterone Impairs the Expression and Distribution of Sex Steroid Receptors during Endometrial Receptivity Development in Female Sprague-Dawley Rats.Int J Mol Sci. 2024 Sep 23;25(18):10202. doi: 10.3390/ijms251810202. Int J Mol Sci. 2024. PMID: 39337689 Free PMC article.
-
Modulating Morphological and Redox/Glycative Alterations in the PCOS Uterus: Effects of Carnitines in PCOS Mice.Biomedicines. 2023 Jan 27;11(2):374. doi: 10.3390/biomedicines11020374. Biomedicines. 2023. PMID: 36830911 Free PMC article.
-
The Pathophysiological Mechanism and Clinical Treatment of Polycystic Ovary Syndrome: A Molecular and Cellular Review of the Literature.Int J Mol Sci. 2024 Aug 20;25(16):9037. doi: 10.3390/ijms25169037. Int J Mol Sci. 2024. PMID: 39201722 Free PMC article. Review.
-
Association between Pre-Pregnancy Overweightness/Obesity and Pregnancy Outcomes in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.Int J Environ Res Public Health. 2022 Jul 26;19(15):9094. doi: 10.3390/ijerph19159094. Int J Environ Res Public Health. 2022. PMID: 35897496 Free PMC article.
References
-
- Abuelezz N. Z., Shabana M. E., Abdel-Mageed H. M., Rashed L., Morcos G. N. B. (2020). Nanocurcumin alleviates insulin resistance and pancreatic deficits in polycystic ovary syndrome rats: insights on PI3K/AkT/mTOR and TNF-α modulations. Life Sci. 256:118003. doi: 10.1016/j.lfs.2020.118003, PMID: - DOI - PubMed
-
- Alkhuriji A. F., Al Omar S. Y., Babay Z. A., El-Khadragy M. F., Mansour L. A., Alharbi W. G., et al. . (2020). Association of IL-1β, IL-6, TNF-α, and TGFβ1 gene polymorphisms with recurrent spontaneous abortion in polycystic ovary syndrome. Dis. Markers 2020:6076274. doi: 10.1155/2020/6076274, PMID: - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials